Clinical Characteristics of Vasculitic Ulcers
Vasculitic ulcers are inflammatory ulcers caused by blood vessel wall destruction, typically presenting as painful, multiple lesions predominantly on the lower legs and feet, with characteristic features including purpura, hemorrhagic vesicles, violaceous raised edges, and surrounding inflammatory changes. 1, 2
Key Clinical Features
Location and Distribution
- Predominantly lower extremities (legs and feet) where microcirculatory anatomy and rheologic dynamics create predisposing factors 2
- Often multiple ulcers rather than solitary lesions 2
- May affect the dorsum of the foot 3
Morphologic Characteristics
- Painful lesions (distinguishing feature from venous ulcers) 3
- Violaceous, well-defined, raised edges with surrounding edematous halo 3
- Purpura as a common presenting sign 4
- Hemorrhagic vesicles may precede ulceration 4
- Granulation tissue with fibrinopurulent membranes in the ulcer base 3
- Perilesional hyperpigmentation and crusting 3
Associated Cutaneous Manifestations
The spectrum of vasculitic skin changes includes:
- Urticaria
- Palpable purpura
- Nodules
- Livedo reticularis
- Digital infarcts or gangrene
- Necrotic areas 4
Pathophysiology and Clinical Context
Vasculitic ulcers result from inflammatory destruction of blood vessel walls (arterioles, capillaries, postcapillary venules), leading to impaired blood flow, focal ischemia, and subsequent ulceration 2. This distinguishes them from vasculopathies (like livedoid vasculopathy), where vascular occlusion without primary inflammation is the main mechanism 5.
Epidemiology
- Account for approximately 3-5% of all skin ulcers 2
- Can occur as isolated cutaneous disease or as manifestation of systemic vasculitis 2, 4
Diagnostic Approach
Clinical Red Flags
- Spontaneous ulcers without clear vascular insufficiency or trauma 3
- Non-healing ulcers refractory to standard wound care and antibiotics 6, 3
- Adequate arterial supply on vascular assessment yet poor healing 6
- Absence of peripheral neuropathy 6
Laboratory Evaluation
When vasculitic ulcer is suspected:
- Inflammatory markers: Elevated C-reactive protein and erythrocyte sedimentation rate 3
- Autoimmune screening:
Histopathology
Skin biopsy is pivotal for definitive diagnosis 6:
- Inflammatory cell infiltration and destruction of blood vessel walls 4
- Abundant neutrophils in the dermis 3
- Fibrinoid necrosis of small vessels 6
- Leukocytoclastic changes
- Fibrin deposition extending into deeper dermis 6
Imaging
- Vascular studies to exclude primary arterial insufficiency 6
- May require invasive venography or non-invasive vascular studies 7
Clinical Pitfalls
Common Misdiagnoses
- Chronic venous insufficiency: Vasculitic ulcers are more painful and have inflammatory borders 2
- Arterial ulcers: Vascular studies show adequate perfusion in vasculitic ulcers 6
- Pyoderma gangrenosum: Can mimic vasculitic ulcers; biopsy helps differentiate 6
- Infection alone: Vasculitic ulcers may become secondarily infected but won't heal with antibiotics alone 6, 3
Management Considerations for Behçet's Syndrome
Leg ulcers in Behçet's require special attention as they may be associated with:
- Venous stasis from deep vein thrombosis
- Obliterative vasculitis causing arterial ischemia
- Pyoderma gangrenosum 8
Management requires interdisciplinary collaboration with dermatology and vascular surgery, potentially needing immunosuppressives, antibiotics for superinfection, debridement, or compression bandaging 8.
Systemic Associations
Vasculitic ulcers may indicate:
- Primary vasculitic syndromes: Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis 4
- Connective tissue diseases: Lupus, rheumatoid arthritis, dermatomyositis 7, 3
- Secondary causes: Infections, drug reactions, malignancy 4
- Blood dyscrasias: Sickle cell disease, thalassemia 7
Rheumatoid vasculitis deserves particular mention as it represents the most serious extra-articular manifestation of RA, with >40% mortality at 5 years after onset, though it's rare and typically occurs in longstanding disease 3.